Working… Menu

Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03300115
Recruitment Status : Unknown
Verified February 2019 by Hangzhou ACEA Pharmaceutical Research Co., Ltd..
Recruitment status was:  Recruiting
First Posted : October 3, 2017
Last Update Posted : February 19, 2019
Guangdong Provincial People's Hospital
Information provided by (Responsible Party):
Hangzhou ACEA Pharmaceutical Research Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 17, 2019
Estimated Study Completion Date : December 17, 2020